Complete Filing Data
SkinHealth Systems Inc. reported Stockholders Equity of $61.06 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SkinHealth Systems Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$9.5M | -$29.1M | -$100.1M | $44.2M | -$378.8M | -$29.2M | -$1.6M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $5.5M | -$3.9M | $1.5M | -$3.3M | -$1.5M | $79.0K | $33.0K |
| Operating Income Loss | -$20.8M | -$67.8M | -$130.9M | -$25.8M | -$39.9M | -$17.2M | $13.5M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$5.9M | -$29.6M | -$101.9M | $45.3M | -$380.6M | -$38.5M | -$2.9M |
| Income Tax Expense Benefit | $3.6M | -$452.0K | -$1.8M | $1.1M | -$1.9M | -$9.3M | -$1.3M |
| Selling And Marketing Expense | $93.6M | $118.3M | $144.5M | $160.1M | $111.6M | $50.3M | $61.8M |
| Revenue From Contract With Customer Excluding Assessed Tax | $300.8M | $334.3M | $398.0M | $365.9M | $260.1M | $119.1M | $166.6M |
| Research And Development Expense | $5.6M | $6.3M | $10.1M | $8.4M | $8.2M | $3.4M | $4.6M |
| Other Nonoperating Income Expense | $18.9M | $33.6M | $5.2M | -$1.7M | -$4.5M | -$47.0K | $535.0K |
| Operating Expenses | $217.2M | $250.1M | $286.0M | $274.6M | $218.5M | $84.4M | $93.1M |
| Gross Profit | $196.4M | $182.3M | $155.1M | $248.8M | $178.5M | $67.2M | $106.5M |
| General And Administrative Expense | $117.9M | $125.5M | $131.4M | $106.1M | $98.7M | $30.6M | $26.7M |
| Cost Of Revenue | $104.4M | $152.0M | $242.9M | $117.1M | $81.5M | $51.9M | $60.1M |
| Comprehensive Income Net Of Tax | -$4.0M | -$33.0M | -$98.6M | $41.0M | -$380.3M | -$29.1M | -$1.6M |
| Amortization Of Intangible Assets | $17.0M | $19.5M | $20.9M | $14.9M | $13.3M | $11.8M | $12.5M |
| Income Taxes Receivable | $1.7M | $818.0K | $332.0K | $1.3M | $4.6M | $4.6M | |
| Deferred Income Tax Liabilities Net | $393.0K | $396.0K | $702.0K | $2.0M | $3.6M | $4.0M | |
| Deferred Income Tax Assets Net | $1.9M | $3.9M | $531.0K | $815.0K | $330.0K | $270.0K | |
| Accrued Income Taxes Current | $1.2M | $3.4M | $2.8M | $1.4M | $292.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$11.0M | $19.7M | -$10.1M | -$18.3M | $202.0K | -$679.0K | -$73.8M | $3.4M | -$20.3M | -$81.0K | $6.3M | $31.5M | -$215.1M | -$139.4M | -$3.3M | -$2.2M | -$10.4M | -$9.1M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $421.0K | $3.6M | $1.1M | $1.2M | -$816.0K | -$1.0M | -$1.1M | -$367.0K | $888.0K | -$1.6M | -$3.7M | -$145.0K | -$1.5M | -$276.0K | -$5.0K | $108.0K | -$16.0K | -$72.0K |
| Operating Income Loss | -$6.2M | -$2.7M | -$12.0M | -$21.5M | -$22.1M | -$17.0M | -$82.1M | -$13.1M | -$17.3M | -$4.4M | -$5.0M | -$14.0M | -$5.5M | -$26.4M | $2.4M | $2.8M | -$7.9M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$10.6M | $18.7M | -$9.2M | -$16.3M | -$151.0K | -$1.3M | -$70.3M | $1.2M | -$23.9M | -$902.0K | $6.4M | $34.1M | -$216.3M | -$141.2M | -$3.6M | -$2.8M | -$13.4M | |
| Income Tax Expense Benefit | $386.0K | -$993.0K | $892.0K | $1.9M | -$353.0K | -$659.0K | $3.5M | -$2.2M | -$3.7M | -$821.0K | $76.0K | $2.6M | -$1.1M | -$1.9M | -$306.0K | -$593.0K | -$3.1M | |
| Selling And Marketing Expense | $20.9M | $23.1M | $26.0M | $27.6M | $30.5M | $33.7M | $30.7M | $43.0M | $38.7M | $39.8M | $44.9M | $36.4M | $30.5M | $26.2M | $17.1M | $10.5M | $6.2M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $70.7M | $78.2M | $69.6M | $78.8M | $90.6M | $81.4M | $97.4M | $117.5M | $86.3M | $88.8M | $103.5M | $75.4M | $68.1M | $66.5M | $47.5M | $34.6M | $14.1M | |
| Research And Development Expense | $1.7M | $1.3M | $998.0K | $1.1M | $1.2M | $2.8M | $1.8M | $2.9M | $2.3M | $2.2M | $2.6M | $2.2M | $1.9M | $3.0M | $1.5M | $577.0K | $597.0K | |
| Other Nonoperating Income Expense | $601.0K | $18.1M | $60.0K | $69.0K | $17.3M | $16.1M | $4.9M | $47.0K | $418.0K | -$361.0K | $915.0K | -$934.0K | $24.0K | -$4.3M | -$7.0K | $23.0K | $56.0K | |
| Operating Expenses | $51.9M | $51.8M | $60.6M | $62.2M | $63.1M | $65.4M | $69.5M | $81.0M | $71.4M | $65.7M | $75.1M | $64.9M | $51.5M | $73.6M | $29.4M | $18.2M | $12.2M | |
| Gross Profit | $45.6M | $49.1M | $48.6M | $40.6M | $40.9M | $48.4M | -$12.6M | $67.9M | $54.1M | $61.4M | $70.0M | $50.9M | $46.1M | $47.3M | $31.7M | $21.0M | $4.3M | |
| General And Administrative Expense | $29.3M | $27.5M | $33.6M | $33.4M | $31.4M | $28.9M | $37.0M | $35.1M | $30.4M | $23.8M | $27.6M | $26.3M | $19.2M | $44.4M | $10.8M | $7.1M | $5.4M | |
| Cost Of Revenue | $25.0M | $29.1M | $21.0M | $38.2M | $49.7M | $33.0M | $110.0M | $49.6M | $32.2M | $27.4M | $33.5M | $24.5M | $22.1M | $19.3M | $15.8M | $13.6M | $9.8M | |
| Comprehensive Income Net Of Tax | -$10.6M | $23.3M | -$9.0M | -$17.1M | -$614.0K | -$1.7M | -$74.9M | $3.0M | -$19.4M | -$1.7M | $2.6M | $31.3M | -$216.7M | -$139.7M | -$3.3M | -$2.1M | -$10.4M | |
| Amortization Of Intangible Assets | $3.2M | $5.0M | $3.9M | $3.6M | $2.9M | |||||||||||||
| Income Taxes Receivable | $3.2M | $2.1M | $274.0K | $399.0K | $401.0K | $1.2M | $989.0K | $5.6M | $1.6M | $705.0K | $1.0M | $1.8M | $4.9M | $4.3M | ||||
| Deferred Income Tax Liabilities Net | $112.0K | $217.0K | $402.0K | $1.1M | $1.1M | $1.1M | $2.3M | $2.0M | $2.9M | $3.7M | $3.8M | $3.8M | $2.7M | $1.3M | ||||
| Deferred Income Tax Assets Net | $985.0K | $3.2M | $4.3M | $1.2M | $3.0M | $1.9M | $798.0K | $811.0K | $831.0K | $268.0K | $312.0K | $330.0K | $1.0M | $482.0K | ||||
| Accrued Income Taxes Current | $1.5M | $2.7M | $3.3M | $1.4M | $2.4M | $3.4M | $2.0M | $3.2M | $1.2M | $1.1M | $2.5M | $4.2M | $2.2M | $764.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $61.1M | $51.8M | $59.4M | $167.1M | $298.0M | -$30.6M | -$1.2M | $294.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $232.7M | $370.1M | $523.0M | $568.2M | $901.9M | $9.5M | $7.3M | $3.6M |
| Goodwill | $126.6M | $123.5M | $125.8M | $124.6M | $123.7M | $98.5M | $98.5M | $98.1M |
| Retained Earnings Accumulated Deficit | -$517.5M | -$508.0M | -$478.9M | -$378.8M | -$418.7M | -$43.6M | ||
| Liabilities Current | $186.3M | $68.2M | $115.0M | $71.7M | $76.4M | $30.9M | ||
| Liabilities And Stockholders Equity | $499.8M | $685.7M | $929.1M | $1.00B | $1.22B | $222.8M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$142.6M | -$149.0M | -$47.2M | -$330.7M | $892.9M | $2.0M | $3.8M | |
| Assets | $499.8M | $685.7M | $929.1M | $1.00B | $1.22B | $222.8M | ||
| Other Amortization Of Deferred Charges | $4.5M | $4.2M | $2.4M | $857.0K | $147.0K | $132.0K | $63.0K | |
| Liabilities | $438.7M | $633.9M | $869.7M | $836.0M | $916.5M | $252.8M | ||
| Employee Related Liabilities Current | $24.9M | $17.6M | $22.0M | $21.7M | $28.7M | $9.5M | ||
| Assets Current | $309.5M | $477.1M | $698.3M | $783.3M | $1.00B | $59.1M | ||
| Accrued Liabilities Current | $15.4M | $20.0M | $19.8M | $15.2M | $14.7M | $2.5M | ||
| Allowance For Doubtful Accounts Receivable Current | $6.0M | $9.6M | $6.6M | $2.9M | $2.7M | $2.0M | ||
| Other Assets Noncurrent | $11.9M | $14.1M | $16.0M | $14.2M | $6.7M | $4.8M | ||
| Inventory Net | $48.0M | $69.1M | $91.3M | $109.7M | $35.3M | $23.2M | ||
| Finite Lived Intangible Assets Net | $35.8M | $47.5M | $62.1M | $46.4M | $56.0M | $50.9M | ||
| Common Stock Value | $13.0K | $12.0K | $12.0K | $14.0K | $16.0K | $4.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.4M | -$7.0M | -$3.0M | -$4.5M | -$1.3M | $242.0K | ||
| Accounts Receivable Net Current | $21.7M | $27.6M | $54.7M | $76.5M | $46.8M | $18.6M | ||
| Accounts Payable Current | $15.6M | $21.9M | $44.8M | $28.5M | $29.0M | $18.5M | ||
| Convertible Debt Noncurrent | $240.4M | $552.2M | $738.4M | $734.1M | $729.9M | $0.00 | ||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | $2.5M | $6.0M | $14.2M | $18.2M | $16.2M | $9.2M | ||
| Prepaid Expense And Other Assets Current | $5.4M | $9.5M | $28.9M | $27.6M | $12.3M | $3.2M | ||
| Operating Lease Right Of Use Asset | $11.6M | $13.6M | $12.1M | $15.6M | $15.0M | $0.00 | ||
| Operating Lease Liability Noncurrent | $9.2M | $10.8M | $9.3M | $12.7M | $12.8M | $0.00 | ||
| Operating Lease Liability Current | $5.1M | $5.1M | $4.6M | $5.0M | $3.7M | $0.00 | ||
| Other Liabilities Noncurrent | $2.4M | $2.3M | $2.8M | $0.00 | $1.9M | |||
| Payment For Contingent Consideration Liability Financing Activities | $0.00 | $0.00 | $1.8M | $4.3M | $0.00 | $0.00 | $0.00 | |
| Cash And Cash Equivalents At Carrying Value | $523.0M | $568.2M | $901.9M | $9.5M | ||||
| Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability | $0.00 | $0.00 | $47.1M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $65.7M | $74.0M | $46.1M | $59.7M | $69.2M | $63.3M | $90.0M | $161.8M | $152.4M | $250.8M | $345.4M | $336.4M | -$142.1M | $16.1M | -$33.2M | -$22.5M | -$20.5M | -$10.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $219.4M | $212.0M | $373.0M | $358.9M | $349.5M | $444.6M | $559.4M | $549.7M | $532.3M | $684.2M | $821.0M | $859.2M | $718.6M | $101.5M | $14.1M | $11.8M | $14.6M | ||
| Goodwill | $126.5M | $126.3M | $124.3M | $125.5M | $124.8M | $125.4M | $124.7M | $125.4M | $125.2M | $122.7M | $124.0M | $123.8M | $122.9M | $103.1M | $98.5M | $98.5M | $98.5M | ||
| Retained Earnings Accumulated Deficit | -$509.4M | -$498.3M | -$518.1M | -$497.6M | -$479.3M | -$479.5M | -$469.5M | -$395.6M | $4.7M | -$378.1M | -$378.3M | -$386.2M | -$401.4M | -$186.3M | -$68.0M | -$1.5K | |||
| Liabilities Current | $61.9M | $59.4M | $62.8M | $73.9M | $75.4M | $93.6M | $125.9M | $82.8M | $72.3M | $76.4M | $87.1M | $68.9M | $49.5M | $39.5M | $813.5K | $414.1K | |||
| Liabilities And Stockholders Equity | $503.6M | $507.6M | $673.8M | $699.5M | $711.8M | $844.7M | $973.1M | $1.01B | $995.0M | $1.10B | $1.21B | $1.20B | $997.9M | $342.5M | $463.5M | $437.6K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $1.6M | -$77.3M | -$36.9M | -$42.7M | $4.7M | $25.0K | |||||||||||||
| Assets | $503.6M | $507.6M | $673.8M | $699.5M | $711.8M | $844.7M | $973.1M | $1.01B | $995.0M | $1.10B | $1.21B | $1.20B | $997.9M | $342.5M | $463.5M | $437.6K | |||
| Other Amortization Of Deferred Charges | $1.1M | $890.0K | $548.0K | $135.0K | $33.0K | ||||||||||||||
| Liabilities | $438.0M | $433.6M | $627.8M | $639.8M | $642.6M | $781.4M | $883.1M | $845.6M | $847.3M | $846.9M | $862.6M | $857.5M | $1.14B | $326.4M | $68.4M | ||||
| Employee Related Liabilities Current | $18.8M | $15.0M | $14.5M | $16.5M | $17.1M | $15.5M | $20.8M | $26.2M | $18.7M | $20.7M | $27.8M | $21.4M | $21.3M | $18.3M | $12.0K | ||||
| Assets Current | $308.4M | $306.1M | $469.4M | $485.0M | $489.6M | $614.8M | $738.0M | $767.9M | $748.5M | $892.4M | $995.8M | $982.4M | $797.8M | $174.4M | $3.3M | ||||
| Accrued Liabilities Current | $19.3M | $13.6M | $16.7M | $28.1M | $24.0M | $24.4M | $30.5M | $19.1M | $13.1M | $17.1M | $15.4M | $12.4M | $7.9M | $801.5K | $1.0K | ||||
| Allowance For Doubtful Accounts Receivable Current | $7.4M | $8.0M | $9.5M | $11.0M | $8.3M | $7.2M | $4.8M | $4.0M | $3.8M | $2.9M | $2.5M | $2.5M | $2.7M | $2.7M | |||||
| Other Assets Noncurrent | $13.1M | $13.3M | $13.6M | $14.7M | $15.5M | $15.8M | $15.5M | $16.1M | $15.6M | $10.3M | $9.8M | $8.0M | $4.8M | $2.5M | |||||
| Inventory Net | $56.1M | $59.2M | $65.6M | $73.4M | $77.1M | $95.7M | $74.9M | $107.0M | $122.1M | $101.7M | $73.5M | $47.0M | $28.1M | $23.8M | |||||
| Finite Lived Intangible Assets Net | $38.0M | $43.5M | $45.6M | $51.0M | $54.2M | $58.4M | $64.6M | $65.6M | $70.8M | $46.6M | $51.2M | $52.5M | $59.3M | $51.9M | |||||
| Common Stock Value | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | $12.0K | $14.0K | $14.0K | $14.0K | $15.0K | $16.0K | $16.0K | $14.0K | $13.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.8M | -$2.2M | -$5.8M | -$3.7M | -$4.9M | -$4.1M | -$5.1M | -$4.0M | -$3.6M | -$6.7M | -$5.1M | -$1.4M | -$1.6M | -$39.0K | |||||
| Accounts Receivable Net Current | $22.2M | $25.0M | $23.3M | $36.3M | $41.4M | $47.7M | $66.8M | $74.6M | $70.8M | $84.0M | $79.9M | $60.8M | $38.4M | $40.1M | |||||
| Accounts Payable Current | $17.3M | $23.0M | $23.1M | $23.1M | $26.7M | $37.3M | $35.9M | $29.4M | $34.3M | $32.6M | $36.8M | $27.0M | $18.1M | $17.3M | |||||
| Convertible Debt Noncurrent | $363.4M | $363.1M | $553.0M | $551.4M | $550.6M | $665.5M | $737.3M | $736.3M | $735.2M | $733.1M | $732.0M | $731.0M | $728.9M | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | $3.1M | $3.7M | $4.2M | $7.6M | $9.7M | $12.0M | $16.1M | $18.0M | $18.4M | $18.1M | $18.0M | $17.9M | |||||||
| Prepaid Expense And Other Assets Current | $7.4M | $7.8M | $7.2M | $16.0M | $21.1M | $25.6M | $35.9M | $30.9M | $21.7M | $21.8M | $20.3M | $13.6M | |||||||
| Operating Lease Right Of Use Asset | $13.6M | $11.5M | $12.5M | $14.6M | $14.9M | $16.4M | $13.3M | $13.8M | $15.6M | $14.3M | $15.8M | $14.3M | |||||||
| Operating Lease Liability Noncurrent | $10.6M | $8.5M | $9.6M | $12.1M | $12.7M | $13.7M | $10.1M | $10.6M | $12.3M | $11.4M | $13.1M | $12.0M | |||||||
| Operating Lease Liability Current | $5.0M | $5.2M | $5.1M | $4.8M | $4.3M | $4.6M | $4.7M | $4.9M | $4.9M | $5.0M | $4.5M | $4.0M | |||||||
| Other Liabilities Noncurrent | $1.9M | $2.0M | $1.8M | $699.0K | $1.8M | $2.6M | $410.0K | $979.0K | $11.0K | $0.00 | $1.8M | $1.8M | |||||||
| Payment For Contingent Consideration Liability Financing Activities | $0.00 | $783.0K | $0.00 | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $559.4M | $549.7M | $532.3M | $684.2M | $821.0M | $859.2M | $718.6M | $101.5M | $2.8M | $25.0K | |||||||||
| Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability | $0.00 | $0.00 | $10.6M | $36.5M | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $37.5M | $16.1M | $21.8M | -$106.6M | -$28.4M | -$12.4M | $1.7M |
| Share Based Compensation | $14.8M | $26.7M | $22.5M | $28.5M | $12.4M | $363.0K | $103.0K |
| Net Cash Provided By Used In Financing Activities | -$174.9M | -$158.3M | -$37.4M | -$205.2M | $959.0M | $18.3M | $14.6M |
| Net Cash Provided By Used In Investing Activities | -$5.2M | -$6.8M | -$31.5M | -$18.9M | -$37.7M | -$3.8M | -$12.5M |
| Payments To Acquire Property Plant And Equipment | $303.0K | $756.0K | $3.8M | $10.8M | $11.2M | $3.5M | $8.8M |
| Payments To Acquire Intangible Assets | $4.9M | $6.0M | $9.2M | $6.5M | $4.4M | $316.0K | $1.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$3.4M | -$15.5M | $7.0M | $13.8M | $5.1M | -$489.0K | $1.1M |
| Increase Decrease In Inventories | -$15.8M | $10.5M | $22.6M | $84.4M | $7.3M | $3.2M | $4.8M |
| Increase Decrease In Accounts Receivable | -$5.2M | -$20.8M | -$16.5M | $32.0M | $31.0M | -$3.7M | $11.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.2M | -$4.0M | $2.0M | -$3.0M | -$543.0K | $159.0K | -$94.0K |
| Adjustments Related To Tax Withholding For Share Based Compensation | $1.6M | $1.9M | $3.2M | $927.0K | |||
| Payments Related To Tax Withholding For Share Based Compensation | $1.6M | $2.0M | $3.2M | $927.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $3.0M | -$16.9M | -$13.0M | -$38.5M | $1.3M | -$540.00 | ||||||||
| Share Based Compensation | $2.5M | $5.3M | $3.5M | $7.7M | $6.5M | $6.6M | $3.6M | $7.0M | $34.0K | |||||
| Net Cash Provided By Used In Financing Activities | -$250.0K | -$58.6M | -$2.2M | -$783.0K | $4.4M | $25.5K | ||||||||
| Net Cash Provided By Used In Investing Activities | -$1.1M | -$1.8M | -$21.7M | -$3.4M | -$988.0K | |||||||||
| Payments To Acquire Property Plant And Equipment | $45.0K | $344.0K | $2.3M | $3.1M | $818.0K | |||||||||
| Payments To Acquire Intangible Assets | $1.1M | $1.5M | $2.5M | $276.0K | $170.0K | |||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.9M | -$1.9M | $1.3M | -$1.3M | $975.0K | |||||||||
| Increase Decrease In Inventories | -$3.8M | $11.1M | $13.9M | $11.5M | -$1.4M | |||||||||
| Increase Decrease In Accounts Receivable | -$4.0M | -$5.9M | -$4.8M | $14.2M | $8.5M | |||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.4M | -$1.1M | $974.0K | $30.0K | -$21.0K | |||||||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $188.0K | $708.0K | $250.0K | $73.0K | $368.0K | $1.0M | $331.0K | $545.0K | $2.2M | $370.0K | $495.0K | |||
| Payments Related To Tax Withholding For Share Based Compensation | $250.0K | $868.0K | $2.2M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.16 | -$0.36 | -$0.76 | -$0.23 | -$3.71 | -$0.85 | -$0.05 |
| Weighted Average Number Of Shares Outstanding Basic | 126.4M | 123.8M | 131.7M | 147.6M | 102.1M | 34.3M | 32.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 135.8M | 142.5M | 131.7M | 148.5M | 102.1M | 34.3M | 32.1M |
| Earnings Per Share Basic | $-0.08 | $-0.23 | $-0.76 | $0.30 | $-3.71 | $-0.85 | $-0.05 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 127.5M | 124.9M | 122.9M | 132.2M | 150.6M | 35.5M | 32.1M |
| Common Stock Shares Issued | 127.5M | 124.9M | 122.9M | 132.2M | 150.6M | 35.5M | 32.1M |
| Common Stock Shares Authorized | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.09 | $0.03 | -$0.08 | -$0.15 | -$0.10 | -$0.10 | -$0.56 | $0.03 | -$0.15 | -$0.03 | -$0.06 | -$0.13 | -$1.63 | -$1.52 | -$0.09 | -$0.06 | -$0.30 |
| Weighted Average Number Of Shares Outstanding Basic | 126.9M | 126.1M | 125.1M | 124.1M | 123.7M | 123.1M | 132.9M | 132.7M | 132.4M | 150.8M | 150.7M | 150.6M | 132.3M | 91.8M | 35.5M | 35.4M | 34.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 126.9M | 140.3M | 125.1M | 124.1M | 141.9M | 144.5M | 132.9M | 132.7M | 132.4M | 151.4M | 151.7M | 152.7M | 132.3M | 91.8M | 35.5M | 35.4M | 34.5M |
| Earnings Per Share Basic | $-0.09 | $0.16 | $-0.08 | $-0.15 | $0.00 | $-0.01 | $-0.56 | $0.03 | $-0.15 | $0.00 | $0.04 | $0.21 | $-1.63 | $-1.52 | $-0.09 | $-0.06 | $-0.30 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 127.3M | 126.8M | 125.2M | 124.1M | 124.0M | 123.5M | 132.6M | 132.9M | 132.6M | 143.2M | 150.9M | 150.6M | 133.5M | 125.4M | |||
| Common Stock Shares Issued | 127.3M | 126.8M | 125.2M | 124.1M | 124.0M | 123.5M | 132.6M | 132.9M | 132.6M | 143.2M | 150.9M | 150.6M | 133.5M | 125.4M | |||
| Common Stock Shares Authorized | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $14.8M | $26.7M | $22.5M | $28.5M | $12.4M | $363.0K | $103.0K |
| Fair Value Adjustment Of Warrants | -$487.0K | -$3.1M | -$11.9M | -$78.3M | $277.3M | $0.00 | $0.00 |
| Foreign Currency Transaction Gain Loss Before Tax | $5.8M | -$4.6M | $2.4M | -$1.3M | -$69.0K | $21.0K | $160.0K |
| Depreciation | $3.8M | $9.9M | $11.3M | $7.2M | $4.5M | $2.6M | $1.4M |
| Additional Paid In Capital | $580.0M | $566.7M | $541.3M | $550.3M | $722.3M | $14.0M | |
| Provision For Doubtful Accounts | $2.1M | $5.1M | $5.2M | $1.6M | $854.0K | $1.4M | $659.0K |
| Investment Income Interest | $9.0M | $16.6M | $23.2M | $9.2M | $39.0K | ||
| Warrants And Rights Outstanding | $3.6M | $15.5M | $93.8M | $0.00 | |||
| Amortization Of Financing Costs | $3.6M | $3.3M | $4.2M | $4.2M | |||
| Stock Issued During Period Value Acquisitions | $0.00 | $0.00 | $1.3M | $500.0K | $9.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.5M | $5.3M | $3.5M | $7.7M | $6.5M | $6.6M | $8.2M | $8.5M | $3.6M | $7.4M | $6.4M | $7.0M | $5.1M | $3.5M | $34.0K | $76.0K | $224.0K | $26.0K | |
| Fair Value Adjustment Of Warrants | -$210.0K | $210.0K | -$349.0K | -$418.0K | -$4.0M | $1.5M | -$5.9M | -$11.6M | $9.1M | -$4.3M | -$15.2M | -$52.1M | $199.3M | $72.0M | $0.00 | $0.00 | $0.00 | ||
| Foreign Currency Transaction Gain Loss Before Tax | -$159.0K | $4.5M | $1.9M | $2.3M | -$1.1M | -$1.3M | -$2.3M | $397.0K | $1.1M | $38.0K | -$2.2M | $368.0K | -$431.0K | $24.0K | -$256.0K | $14.0K | $81.0K | ||
| Depreciation | $1.9M | $2.8M | $1.8M | $2.0M | $1.9M | $1.4M | $1.0M | $728.0K | $690.0K | $677.0K | $600.0K | ||||||||
| Additional Paid In Capital | $576.8M | $574.5M | $569.9M | $561.1M | $553.4M | $546.9M | $564.5M | $561.5M | $555.0M | $642.8M | $735.7M | $729.3M | $260.9M | $202.4M | $3.1M | $23.9K | |||
| Provision For Doubtful Accounts | $739.0K | $656.0K | $1.1M | $229.0K | $19.0K | ||||||||||||||
| Investment Income Interest | $1.3M | $3.2M | $3.0M | $4.9M | $4.2M | $5.4M | $6.8M | $5.7M | $4.3M | $2.9M | $743.0K | -$3.0K | |||||||
| Warrants And Rights Outstanding | $139.0K | $349.0K | $139.0K | $488.0K | $558.0K | $976.0K | $5.0M | $7.1M | $13.0M | $24.6M | $22.3M | $26.6M | $41.8M | $357.2M | $157.9M | ||||
| Amortization Of Financing Costs | $786.0K | $951.0K | $1.1M | $1.1M | $0.00 | ||||||||||||||
| Stock Issued During Period Value Acquisitions | $1.3M | $500.0K | $7.8M | $1.6M |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.